Suchergebnisse - "Lee, Mark S"

PubPharm (25)

1

The CD4 transmembrane GGXXG and juxtamembrane (C/F)CV+C motifs mediate pMHCII-specific signaling independently of CD4-LCK interactions

enthalten in: eLife | 2024

von Lee, M. | Tuohy, P. | Kim, C. | +5

UpdateOf: bioRxiv. 2023 Nov 29;:. - PMID 37214965

2

Pharmacokinetics, Safety, and Tolerability of a Single 5-Day Treatment of Tirbanibulin Ointment 1% in 100 cm2 : A Phase 1 Maximal-Use Trial in Patients with Actinic Keratosis

enthalten in: Clinical pharmacology in drug development | 2024

von DuBois, J. | Jones, T. | Lee, M. | +7

3

Pharmacokinetics, Safety, and Tolerability of a Single 5‐Day Treatment of Tirbanibulin Ointment 1% in 100 cm2 : A Phase 1 Maximal‐Use Trial in Patients with Actinic Keratosis

enthalten in: Clinical Pharmacology in Drug Development | 2024

von DuBois, J. | Jones, T. | Lee, M. | +7

4

The CD4 transmembrane GGXXG and juxtamembrane (C/F)CV+C motifs mediate pMHCII-specific signaling independently of CD4-LCK interactions

enthalten in: bioRxiv.org | 2023

von Lee, M. | Tuohy, P. | Kim, C. | +5

5

The CD4 transmembrane GGXXG and juxtamembrane (C/F)CV+C motifs mediate pMHCII-specific signaling independently of CD4-LCK interactions

enthalten in: bioRxiv : the preprint server for biology | 2023

von Lee, M. | Tuohy, P. | Kim, C. | +5

UpdateIn: Elife. 2024 Apr 19;12:. - PMID 38639990

6

A biomimetic five-module chimeric antigen receptor (^5MCAR) designed to target and eliminate antigen-specific T cells

enthalten in: bioRxiv.org | 2023

von Kobayashi, S. | Thelin, M. | Parrish, H. | +6

7

MULTIFUNCTIONAL IMMUNOGLOBULIN-FOLD POLYPEPTIDES FROM ALTERNATIVE TRANSLATIONAL INITIATION AND TERMINATION

enthalten in: Europäisches Patentamt | 2023

von KUHNS MICHAEL S | LEE MARK S | BHATTACHARYA DEEPTA

8

Safety, pharmacokinetics, and efficacy of ruxolitinib cream in children and adolescents with atopic dermatitis

enthalten in: Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology | 2023

von Leung, D. | Paller, A. | Zaenglein, A. | +7

9

Enhancing and inhibitory motifs have coevolved to regulate CD4 activity

enthalten in: bioRxiv.org | 2022

von Lee, M. | Tuohy, P. | Kim, C. | +4

10

Two Phase 3, Randomized, Controlled Trials of Ruxolitinib Cream for Vitiligo

enthalten in: The New England journal of medicine | 2022

von Rosmarin, D. | Passeron, T. | Pandya, A. | +109

CommentIn: N Engl J Med. 2022 Oct 20;387(16):1515-1516. - PMID 36260796